reports
QuinStreet to Participate at Upcoming Investor Conferences
FOSTER CITY, Calif.--(BUSINESS WIRE)-- QuinStreet, Inc. (Nasdaq: QNST), a leader in performance marketplaces and technologies for the financial services and home services industries, today announced that management will participate at the B. Riley Securities 24th Annual Institutional Investor Conference on May 22 at the Beverly Hilton Hotel in California and the BMO Insurance Summit on June 13 at the Lotte New York Palace in New York. The Company looks forward to discussing the details of its performance momentum, market opportunity, and business model with investors. About QuinStreet Qu...
Fifth Third Launches New Payables Solution to Solve Clients’ Jobs to B...
CINCINNATI--(BUSINESS WIRE)-- Fifth Third (NASDAQ:FITB) and Bottomline announced the launch of Enhanced Payables powered by Bottomline and its business payments network, Paymode-X. The solution combines the capabilities of Bottomline’s industry-leading business payments technology with Fifth Third’s extensive banking services to provide customers with a comprehensive suite of payment options. With this new offering, customers can streamline their payment processes, improve cash flow management, and enhance overall operational efficiency. Bottomline data suggests that over 50% of businesses u...
Scholar Rock to Host Investor Day on May 22, 2024
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced it will host an Investor Day on Wednesday, May 22, 2024 beginning at 8:30 a.m. ET in New York City. The Investor Day will feature presentations by members of Scholar Rock’s executive management team about the Company’s myostatin inhibition programs in SMA and obesity, as well as commentary f...
Outlook Therapeutics® Announces UK Submission of Marketing Authorizati...
Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5010 as a Treatment for Wet AMD UK submission for national MAA review follows recently received positive opinion from Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) concerning the authorization of ONS-5010/LYTENAVA™ (bevacizumab gamma) ISELIN, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve regulatory approval for the first authorized use of an ophthalmic formulatio...
Cabaletta Bio to Participate in the H.C. Wainwright 2nd Annual BioConn...
Cabaletta Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ PHILADELPHIA, May 13, 2024 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune diseases, today announced that the Company will participate in a fireside chat at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ on Monday, May 20, 2024 at 9:30 a.m. ET in New York, NY. A live webcast of the prese...
Leading Independent Proxy Advisory Firm ISS Recommends Shareholders Vo...
Leading Independent Proxy Advisory Firm ISS Recommends Shareholders Vote “FOR” All of Crown Castle’s Director Nominees Crown Castle Urges Shareholders to Vote “FOR” ONLY Crown Castle’s 12 Highly Qualified Nominees on the WHITE Proxy Card or Voting Instruction Form Today HOUSTON, May 13, 2024 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) (“Crown Castle” or the “Company”) today announced that Institutional Shareholder Services (ISS), a leading independent proxy advisory firm, has recommended that shareholders vote on the WHITE proxy card or voting instruction form “FOR” ONLY all 12 of...
MacroGenics to Participate in Upcoming Investor Conferences
MacroGenics to Participate in Upcoming Investor Conferences ROCKVILLE, MD, May 13, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company's management will participate in the following investor conferences this month: The Citizens JMP Life Sciences Conference (New York). MacroGenics’ President & Chief Executive Officer, Scott Koenig, M.D., Ph.D., will participate in a fireside cha...
- Jonathan Moreland
SHEN SHENANDOAH TELECOMMUNICATIONS COMPANY
SAIA SAIA INC.
RYI RYERSON HOLDING CORPORATION
RM REGIONAL MANAGEMENT CORP
RHP RYMAN HOSPITALITY PROPERTIES INC.
PENN PENN NATIONAL GAMING INC.
LTRX LANTRONIX INC.
KMPR KEMPER CORPORATION
HUBB HUBBELL INCORPORATED CLASS B
HOO HERBALIFE NUTRITION LTD.
FFIN FIRST FINANCIAL BANKSHARES INC
CTRN CITI TRENDS INC.
CNMD CONMED CORPORATION
AXS AXIS CAPITAL HOLDINGS LIMITED
AMH AMERICAN HOMES 4 RENT CLASS A
AIN ALBANY INTERNATIONAL CORP. CLASS A
HWBK HAWTHORN BANCSHARES
EFR ENERGY FUELS
SABR SABRE CORP.
ALPN ALPINE SELECT AG
HTLD HEARTLAND EXPRESS INC.
MAC MACERICH COMPANY
HI HILLENBRAND INC.
GLO CLOUGH GLOBAL OPPORTUNITIES FUND
WDFC WD-40 COMPANY
PK PARK HOTELS & RESORTS INC.
CRVS CORVUS PHARMACEUTICALS
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
EAF GRAFTECH INTERNATIONAL
FRAF FRANKLIN FINANCIAL SERVICES CO.
BBDC BARINGS BDC INC.
GH GUARDANT HEALTH
MCFT MASTERCRAFT BOAT HOLDINGS
HQL TEKLA LIFE SCIENCES INVESTORS
CZR CAESARS ENTERTAINMENT INC
WSC WILLSCOT MOBILE MINI HOLDINGS CORP
PSTV PLUS THERAPEUTICS INC
CTOS CUSTOM TRUCK ONE SOURCE
TBBK INC.
MEGI THE BANCORP
NPCT INC.
RXO_w MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
BYON NUVEEN CORE PLUS IMPACT FD
VSTS_w RXO INC
NBBK BEYON 3D LTD
ASGI VESTIS CORPORATION
EYPT NB BANCORP INC.
DBD ABERDEEN STANDARD GLOBAL INFRASTRUCTURE INCOME FUND
EYEPOINT PHARMACEUTICALS
INC.
DIEBOLD NIXDORF INCORPORATED
Southside Bancshares, Inc. Declares Cash Dividend
Southside Bancshares, Inc. Declares Cash Dividend TYLER, Texas, May 09, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Southside Bancshares, Inc., (NASDAQ:SBSI), parent company of Southside Bank declared a regular quarterly cash dividend of $0.36 per common share. The cash dividend of $0.36 is scheduled for payment on June 6, 2024, to common stock shareholders of record on May 23, 2024. About Southside Bancshares, Inc. Southside Bancshares, Inc. is a bank holding company headquartered in Tyler, Texas, with approximately $8.35 billion in assets as of March 31, 2024, that wholly-owns ...
Farmer Brothers reports third quarter fiscal 2024 financial results an...
Farmer Brothers reports third quarter fiscal 2024 financial results and publishes quarterly shareholder letter Fiscal Q3 2024 net sales of $85.4 million Gross margin increase of 660 basis points year-over-year to 40.1% NORTHLAKE, Texas, May 09, 2024 (GLOBE NEWSWIRE) -- Farmer Bros. Co. (NASDAQ: FARM) today reported its third quarter fiscal 2024 financial results for the period ended March 31, 2024. The company filed its Form 10-Q and published its quarterly shareholder letter, which contains additional details regarding the results. Both of those documents can be found on the section o...
MacroGenics Provides Update on Corporate Progress, First Quarter 2024 ...
MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim TAMARACK Phase 2 Study Data Presentation of interim TAMARACK Phase 2 study data: updated safety and preliminary efficacy of vobra duo in mCRPC patientsConference call scheduled for today at 4:30 p.m. ET ROCKVILLE, Md., May 09, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today provided an update on its recent cor...
Outlook Therapeutics® to Report Financial Results for Second Quarter F...
Outlook Therapeutics® to Report Financial Results for Second Quarter Fiscal Year 2024 on May 16, 2024 and Host Inaugural Quarterly Conference Call and Webcast ISELIN, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an ophthalmic formulation of bevacizumab for the treatment of retinal diseases in the US and the EU, today announced that it will report its financial results for second quarter fiscal year 2024 on Thursday, May 16, 2024. Outlook Therapeutics management will host its inaugur...
QuinStreet to Participate at Upcoming Investment Conferences
FOSTER CITY, Calif.--(BUSINESS WIRE)-- QuinStreet, Inc. (Nasdaq: QNST), a leader in performance marketplaces and technologies for the financial services and home services industries, today announced that management will participate at the 2024 Needham Technology, Media, and Consumer Conference on May 14 at the Westin Grand Central Hotel in New York and the Barrington Research Virtual Spring Investment Conference on May 16. The Company looks forward to discussing the details of its performance momentum, market opportunity, and business model with investors. About QuinStreet QuinStreet, In...
Armada Hoffler Reports First Quarter 2024 Results
Armada Hoffler Reports First Quarter 2024 Results Net Income of $0.17 Per Diluted Share Normalized FFO of $0.33 Per Diluted Share Multifamily Same Store NOI Growth of 2.6% (GAAP) and 2.5% (Cash) Positive Renewal Spreads on Commercial Leases of 11.5% (GAAP) and 3.7% (Cash) Maintained 2024 Full-Year Normalized FFO Guidance Range of $1.21 to $1.27 Per Diluted Share VIRGINIA BEACH, Va., May 09, 2024 (GLOBE NEWSWIRE) -- Armada Hoffler Properties, Inc. (NYSE: AHH) today announced its results for the quarter ended March 31, 2024 and provided an update on current events and earnings guidanc...
- Jonathan Moreland
RM REGIONAL MANAGEMENT CORP
PENN PENN NATIONAL GAMING INC.
HOO HERBALIFE NUTRITION LTD.
FFIN FIRST FINANCIAL BANKSHARES INC
CNMD CONMED CORPORATION
AXS AXIS CAPITAL HOLDINGS LIMITED
AMH AMERICAN HOMES 4 RENT CLASS A
EFR ENERGY FUELS
MAC MACERICH COMPANY
CTOS CUSTOM TRUCK ONE SOURCE
TBBK INC.
VSTS_w THE BANCORP
EYPT INC.
VESTIS CORPORATION
EYEPOINT PHARMACEUTICALS
INC.
QuinStreet Reports Results for Third Quarter Fiscal 2024
FOSTER CITY, Calif.--(BUSINESS WIRE)-- QuinStreet, Inc. (Nasdaq: QNST), a leader in performance marketplaces and technologies for the financial services and home services industries, today announced financial results for the fiscal third quarter ended March 31, 2024. For the fiscal third quarter, the Company reported revenue of $168.6 million. GAAP net loss for the fiscal third quarter was $(7.0) million, or $(0.13) per diluted share. Adjusted net income for the fiscal third quarter was $3.4 million, or $0.06 per diluted share. Adjusted EBITDA for the fiscal third quarter was $7.9 millio...
Fifth Third’s Financial Empowerment Mobile Begins New Season of Suppor...
CINCINNATI--(BUSINESS WIRE)-- Fifth Third’s Financial Empowerment Mobile, commonly known as the eBus, brings financial access and education directly into communities, especially underserved areas. For 2024, the eBus has been reimagined to offer enhanced experiences including immediate checking account opening, face-to-face consultation pods for private conversations, computer workstations for guests and broader services. “At Fifth Third, we believe that lives are improved when people have the knowledge and tools to make wise financial decisions. With the eBus, we deliver financial tools and ...
OPKO Health Reports First Quarter 2024 Business Highlights and Financi...
OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results Conference call begins at 4:30 p.m. Eastern time today MIAMI, May 07, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended March 31, 2024. First quarter business highlights include the following: Entered into an agreement with Labcorp to sell select assets of BioReference Health. The transaction includes the sale of BioReference Health’s laboratory testing businesses focused on clinical diagnostics and women’s health, excludi...
Inspire Medical Systems, Inc. Announces First Quarter 2024 Financial R...
Inspire Medical Systems, Inc. Announces First Quarter 2024 Financial Results and Updates 2024 Outlook Inspire Reports Year-over-YearRevenue Growth of 28% in the First Quarter and Expects Profitability for the Full Year 2024 MINNEAPOLIS, May 07, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter ended March 31, 2024. Recent Business Highl...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.